Delivery Order 36C25922D0042-36C25925N0048

Award Date 10/1/24
Potential Completion Date 9/30/25
Potential Value $348K
Ultimate Awardee
Cardinal Health, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $405,154.73, was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer treatment. These products are delivered to VA medical...
This federal contract award, valued at $801,456.68, was issued by the Veterans Integrated Service Network 21 (VISN 21) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. This delivery order contract has a...
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., to provide radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract, valued at $1,850,745.85, is a delivery order under a larger indefinite delivery vehicle (IDV) contract with the VA's Veterans Integrated Service Network 17. The contract covers the supply of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201,...
This federal contract award, valued at $157,985.87, was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, such as technetium-99m, iodine-123, and fluorine-18 FDG, used in nuclear medicine, oncology, and diagnostic imaging services within the VA healthcare system. The contract is a delivery order under a larger Indefinite Delivery Vehicle...
This $80,260 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. This contract is not set aside for any specific...
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply of radiopharmaceuticals. The contract, valued at $713,585.56, is a delivery order issued by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA). The contract has an ultimate completion date of September 30, 2024, and is structured as a firm fixed-price arrangement. This award does not have a set-aside designation, indicating Cardinal...
This $955,499.55 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of radiopharmaceuticals, including specialized medical isotopes such as technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has an...
This federal contract award was issued by the Veterans Integrated Service Network 23 of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $181,474.01 firm fixed-price delivery order contract is for the supply of radiopharmaceuticals, which are specialized pharmaceutical products used in nuclear medicine, oncology, and diagnostic imaging services. The contract is not set aside for any specific business type. Cardinal Health 414 has...
This federal contract award is for the delivery of radiopharmaceuticals to the Veterans Integrated Service Network 8 (VISN 8), a healthcare system operated by the U.S. Department of Veterans Affairs (VA). The prime contractor is Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. that specializes in providing nuclear medicine products and services to federal agencies. The $1,665,909.11 contract is a delivery order under an Indefinite Delivery Vehicle (IDV) held by Cardinal Health 414...
This federal contract award is for the delivery of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The prime contractor is Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract has an award value of $143,657.73 and a period of performance through September 29, 2024. The contract is a delivery order under an Indefinite Delivery Vehicle (IDV), which allows the VA to order a range of radiopharmaceutical products,...
  • 36C25922D0042
    Indefinite Delivery Contract
  • 36C25922D0042-36C25925N0048
    Delivery Order

This federal contract award, valued at $347,981.58, was issued by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer treatment. These products support nuclear medicine, oncology, and diagnostic imaging services at VA medical centers, military treatment facilities, and National Institutes of Health (NIH) research centers.

The contract is a Delivery Order with a Firm Fixed Price, and it has an ultimate completion date of September 30, 2025. Cardinal Health 414 holds numerous Indefinite Delivery Vehicles (IDVs) with the VA, ranging from approximately $1 million to $39.8 million, which allow for the ongoing supply of radiopharmaceuticals and related products to multiple VA medical centers and networks nationwide. This particular award is not set aside for a specific type of business.

Generated 10/2/24, 9:48 AM